|
US2015320764A1
|
|
Treating female sexual arousal disorder and related symptoms
|
|
AU2014274599A1
|
|
Compositions of Small Molecule Therapeutics
|
|
AU2014201174A1
|
|
Stabilized prostaglandin e composition
|
|
TN2013000547A1
|
|
Reconstitution device
|
|
WO2014028780A2
|
|
Antifungal compounds and methods of use
|
|
US2014170207A1
|
|
Antimicrobial compounds and methods of use
|
|
TW201402125A
|
|
Reconstitution device
|
|
CN105878017A
|
|
Redissolution method and redissolution device
|
|
MX2013011662A
|
|
Methods and compositions for treating raynaud's disease.
|
|
WO2012097160A1
|
|
Rectal delivery method for therapeutic peptides
|
|
CN103930105A
|
|
Active enantiomer of dodecyl 2-(N,N-dimethylamino)-propionate
|
|
AU2011306050A1
|
|
Enhanced transbuccal drug delivery system and compositions
|
|
CN102858364A
|
|
Therapeutic peptide composition and method
|
|
AU2011249043A1
|
|
Compositions of small molecule therapeutics
|
|
EP2343978A1
|
|
Stabilized composition for treating psoriasis
|
|
KR20100106346A
|
|
Device and system for mixing and dispensing components stored separately from one another
|
|
AU2008352018A1
|
|
Methods to inhibit tumor cell growth by using proton pump inhibitors
|
|
US2007191320A1
|
|
Methods of treatment for female sexual arousal disorder
|
|
US2008090911A1
|
|
Stabilized prostaglandin E composition
|
|
MX2007008325A
|
|
Topical stabilized prostaglandin e compound dosage forms.
|
